HSP90AA1 and breast cancer: Subsequently, CCK8 assay was utilized to explore the HSP90AA1 impact on the proliferative viability of BC cells, and the growth efficiency of cancer cells was significantly inhibited after HSP90AA1 knockdown (Fig. 9E).